Infants who receive multiple vaccines as part of the routine vaccination schedule are unlikely to be more susceptible to other infections not targeted by those vaccines in the two years following vaccination,...

Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced today  a partnership under which Themis will provide advanced vaccine development and manufacturing for...

Brazil health officials have confirmed 723 yellow fever cases and 237 deaths in the period from July 1, 2017 to February 28 of this year. On Monday, the Centers for Disease Control and Prevention (CDC)...

Pfizer Canada Inc. has announced the availability of TRUMENBA (meningococcal group B vaccine) in Canada, following approval by Health Canada in October 2017. TRUMENBA is a vaccine indicated to help prevent...

Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is...

An international group of expert scientists, doctors and public health officials has reported that cases of meningococcal group B meningitis and septicemia (MenB) are increasing in China, and have recommended...

Amidst growing concerns over the low uptake of flu shots in Europe, scientists from the Italian National Research Council and the JRC confirm that vaccinations remain the best way forward when it comes...

The Florida Department of Health (FDOH) announced that its joint investigation with Office of the Attorney General’s Medicaid Fraud Control Unit has led to the arrest of Dr. Ishrat Sohail for Medicaid...

In the past five years, Alaska received an average of <1 mumps case report per year.  Starting in August 2017, there has been an increase in mumps activity in Anchorage. To date, 247 confirmed and...

AstraZeneca announced yesterday that the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has voted in favor of a renewed recommendation for the...